Skip to main content
Equibles
BFLY logo

BFLY · Butterfly Network, Inc. · Metrics

Track BFLY — free

Use BFLY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BFLY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.00 -0.10 (-1.41%)
Russell 2000 member Rebalance outlook locked
Customer concentration — top customer 10% of revenue

One customer — 10% of revenue (the three and six months ended June 30, 2026)

“For the three and six months ended June 30, 2026, one customer accounted for more than 10% of the Company’s total revenue.”
View the 10-Q filed Jul 30, 2026
Market Cap
$1.90B
Shares
266.29M
Volume · Oct 21 4.97M Avg daily vol (3M) 5.65M

BFLY metrics

83 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.10
Market cap
$1.90B

Price action

20 metrics
Price change (1W)
-9.8%
Price change (30D)
-10.2%
Price change (3M)
+7.2%
Price change (6M)
+34.1%
Price change (YTD)
+92.4%
Price change (1Y)
+209.7%
Trailing year
Price change (5Y)
-29.5%
52-week high
$9.93
52-week low
$1.97
Change from 52-week high
-26.4%
Change from 52-week low
+271.1%
Annualized volatility
124.6%
Annualized volatility (3M)
94.8%
Beta
3.2
RSI (14D)
40.8
Price vs SMA 50
-12.9%
Price vs SMA 200
+23.2%
Avg volume (3M)
5.66M
Relative volume
0.6
Average dollar volume
$47.13M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
266.29M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
17.4×
reciprocal yield 5.7%
P / book
10.3
reciprocal yield 9.7%
FCF yield
-1.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
52.6%
Operating margin
-70.8%
Trailing 12 months
Net margin
-66.7%
Gross profit (TTM)
$59.04M
Operating profit (TTM)
−$79.38M
Net income (TTM)
−$74.85M
Trailing 12 months
Diluted EPS (TTM)
$-0.29
FCF margin
-25.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.44
Gross profit per diluted share (TTM)
$0.23
Operating profit per diluted share (TTM)
$-0.31
EBITDA per diluted share (TTM)
$-0.76
Net income per diluted share (TTM)
$-0.29
Operating cash flow per diluted share (TTM)
$-0.09
Free cash flow per diluted share (TTM)
$-0.11
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.15
Stock compensation per diluted share (TTM)
$0.09
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+39.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$112.14M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.5%
Year over year · more shares
Revenue CAGR (3Y)
+10.0%
Revenue CAGR (5Y)
+16.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-39.5%
Return on assets
-26.4%
Debt / equity
—
Current ratio
4.1
EBITDA (TTM)
−$153.33M
Free cash flow (TTM)
−$28.04M
Quick ratio
3.1
Interest coverage
-59.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$124.66M
Latest balance sheet
Cash & equivalents
$124.66M
Total assets
$283.00M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$24.02M
Capital expenditures (TTM)
$4.02M
R&D (TTM)
$38.10M
SG&A (TTM)
—
Stock compensation (TTM)
$23.87M
R&D / revenue
34.0%
Stock compensation / revenue
21.3%

Ownership (13F)

9 metrics
13F filers
249
13F filer change QoQ
+8
Institutional ownership
61.3%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+13.2%
Holder tenure
11.5
Price vs estimated holder cost
+46.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.1%

Short interest

3 metrics
Short interest
11.9%
Latest settlement · 4.8 days to cover
Days to cover
4.8d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$36.57M
Insider-sentiment score
7 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1804176 CUSIP 124155102 13F (30d) 28 filings 28 filers Visit website Investor relations